Company: Celltrion Incorporated

Bloomberg ticker: 068270 KS

Market cap: US$24,773m

Background: Celltrion Incorporated is one of Korea’s biggest exporters by value of biosimilar pharmaceutical products; a biosimilar is a cheaper version of a biopharmaceutical, a type of drug which is derived from biological rather than chemical sources. Like with a generic drug, the development costs are low.
 

World Class Benchmarking of Celltrion Inc

(Click on image to enlarge)

• Profitable Growth rank of 9 was down compared to the prior period’s 7th rank
• This is poor performance compared to 350 large Health Care companies worldwide
• Profitability rank of 8 was better than its Growth rank of 9
• Profitability rank of 8 was down compared to the prior period’s 6th rank
• This is below average performance compared to peers
• Growth rank of 9 was down compared to the prior period’s 6th rank
• This is poor performance compared to peers

More By This Author:

Asian Stock: Jinan Acetate Chemical
Asian Stock: Bumi Resources Minerals
Asian Stock - Bangkok Dusit Medical Services